HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara A Byron Selected Research

PD 173074

11/2012Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
2/2009FGFR2 as a molecular target in endometrial cancer.
9/2008Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara A Byron Research Topics

Disease

19Neoplasms (Cancer)
11/2022 - 09/2008
5Endometrial Neoplasms (Endometrial Cancer)
08/2013 - 09/2008
4Melanoma (Melanoma, Malignant)
01/2021 - 01/2009
4Breast Neoplasms (Breast Cancer)
01/2016 - 10/2003
1Neuroblastoma
11/2022
1Diffuse Intrinsic Pontine Glioma
10/2019
1Glioma (Gliomas)
01/2019
1Edema (Dropsy)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2019
1Clinical Deterioration
01/2017
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017
1Communicable Diseases (Infectious Diseases)
05/2016
1Glioblastoma (Glioblastoma Multiforme)
08/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2013
1Carcinoma (Carcinomatosis)
11/2012
1Skin Neoplasms (Skin Cancer)
10/2012
1Carcinogenesis
04/2010
1Craniosynostoses (Craniosynostosis)
02/2009

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
11/2022 - 05/2016
4Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
01/2019 - 09/2008
4Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2008
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2015
3PD 173074IBA
11/2012 - 09/2008
2Temozolomide (Temodar)FDA LinkGeneric
12/2021 - 02/2013
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 10/2012
2Pharmaceutical PreparationsIBA
01/2021 - 01/2018
2Biological ProductsIBA
10/2019 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 01/2015
2LigandsIBA
01/2016 - 02/2009
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
11/2012 - 04/2010
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2012 - 01/2009
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2012 - 01/2009
2Insulin-Like PeptidesIBA
09/2008 - 10/2003
1Eflornithine (Ornidyl)FDA Link
11/2022
1PlatinumIBA
12/2021
1dipinacoline glutamateIBA
10/2019
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
01/2019
1CaspasesIBA
01/2019
1Somatomedin Receptors (Somatomedin Receptor)IBA
01/2016
1Phenobarbital (Luminal)FDA Link
01/2016
1Insulin ReceptorIBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1NucleotidesIBA
01/2015
1Phosphotransferases (Kinase)IBA
08/2013
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
08/2013
1Mebendazole (Anti-Worm)FDA Link
02/2013
1Paclitaxel (Taxol)FDA LinkGeneric
11/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2012
1Cytostatic AgentsIBA
11/2012
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2012
1NF-kappa B (NF-kB)IBA
01/2012
1progesterone receptor BIBA
09/2008
1ProgesteroneFDA LinkGeneric
09/2008
1Small Interfering RNA (siRNA)IBA
09/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2008
1Insulin Receptor Substrate ProteinsIBA
09/2008
1Growth Factor ReceptorsIBA
10/2003

Therapy/Procedure

13Therapeutics
11/2022 - 02/2009
5Precision Medicine
10/2019 - 01/2015
3Drug Therapy (Chemotherapy)
12/2021 - 11/2012
2Immunotherapy
11/2022 - 01/2021